MDH2 and Alzheimer disease: In contrast, MDH was found to be downregulated in experimental models of AD, indicating the differences between molecular data obtained from or postmortem tissue and in vivo studies, which could be influenced by factors such as disease stage, tissue-specific expression, or compensatory mechanisms in response to neurodegeneration [195, 196].